
Medicus Pharma’s Teverelix has demonstrated long-lasting hormone suppression, as well as a favourable safety profile, in new study data. Teverelix …

Medicus Pharma has announced the appointment of Carolyn Bonner as Chief Financial Officer (CFO) in addition to her role as …

Medicus Pharma has announced updates on the progress of SKNJCT-003 and SKNJCT-004, its clinical trials studying the efficacy of a …

